Tumour Vessel-Targeted LIGHT (TNFSF14) Cytokine
A novel vessel-targeted immunomodulatory agent which promotes tumour vessel normalization
- National phase patents have been filed in the US, EP, China, Malaysia, Korea, Japan, Singapore and Hong Kong; claiming a biomolecule and methods of treatment.
- Patent application submitted
- Development partner